SCHEMBL5569549

SCHEMBL5569549

CC(C)(NC(=O)c1ccc(C2(CN3CCCC3)CC2)cc1)C(N)=O

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 6/20 0.48
▸ F2 P00734 1/20 0.48
▸ HSD11B1 P28845 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ P2RY1 P47900 1/20 0.40
▸ HTT P42858 1/20 0.37
▸ SLC6A2 P23975 2/20 0.37
▸ SLC6A4 P31645 2/20 0.37
▸ SLC6A3 Q01959 2/20 0.37
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ HDAC4 P56524 2/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ FPR2 P25090 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5569550 0.86 F10 (0.48) F10F2HSD11B1KCNH2P2RY1
SCHEMBL5566765 0.81 F10 (0.50) F10F2HSD11B1KCNH2P2RY1
SCHEMBL5570724 0.79 F10 (0.50) F10F2SLC6A2SLC6A4SLC6A3
SCHEMBL5570741 0.79 F10 (0.48) F10F2HSD11B1KCNH2P2RY1
SCHEMBL5566762 0.78 F10 (0.47) F10F2SLC6A2SLC6A4SLC6A3
SCHEMBL5567060 0.77 F10 (0.46) F10F2
SCHEMBL5570726 0.77 F10 (0.50) F10F2NPSR1MEN1KMT2A
SCHEMBL5567235 0.76 F10 (0.48) F10F2P2RY1SLC6A2SLC6A4
SCHEMBL5567238 0.76 F10 (0.48) F10F2SLC6A2SLC6A4SLC6A3
SCHEMBL5570744 0.76 F10 (0.48) F10F2P2RY1SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250415-B2 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-07-31 — — US disclosed
EP-1628668-A2 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, BETA-AMINOACIDS, ALPHA-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITO RS Bristol-Myers Squibb Company (US) 2006-03-01 — — EP disclosed
WO-2004108892-A2 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, β-AMINOACIDS, α-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-12-16 — — WO disclosed
Send feedback